KIMBERLY BEHNEY: Open Payments
NPI 1780208090 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 18 payments from 10 companies in 2025. Trend: 2023 $380 · 2024 $101 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $166 |
| AstraZeneca Pharmaceuticals LP | 1 | $110 |
| Novo Nordisk Inc | 3 | $69 |
| Medtronic, Inc. | 2 | $43 |
| IBSA Pharma Inc. | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| BETA BIONICS, INC. | 1 | $12 |
Products named: ZEPBOUND, FARXIGA, Ozempic, MOUNJARO, MINIMED 780G, Tirosint, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN.
Industry payments across FL — which companies pay providers there.
